default image

Urologie

Information and services of the department

  • Number of inpatient cases: 324

Services search (in the department)


Illness Number of cases
Hyperplasia of prostate (N40) 124
Cystitis (N30.2) 83
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9) 41
Malignant neoplasm of prostate (C61) 27
Benign neoplasm of urinary organs - Benign neoplasm of bladder (D30.3) 17
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 10
Malignant neoplasm of ureter (C66) not specified
Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) not specified
Malignant neoplasm of bladder - Malignant neoplasm of bladder neck (C67.5) not specified
Benign neoplasm of male genital organs - Benign neoplasm of prostate (D29.1) not specified
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 322
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 156
Surgical removal or destruction of prostatic tissue through the urethra (5-601.70) 96
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) 41
Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1) 38
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 29
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 26
Insertion, exchange or removal of a ureteral stent (8-137.00) 19
Removal of stones, foreign bodies or collections of blood from the bladder by endoscopy (5-570.0) 15
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) 14

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
26 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
5 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
5 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Participation in multi-centre phase III/IV studies
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
No. Training in other healing professions Comment
HB19 Nursing professionals (ehemals Gesundheits- und Krankenpfleger)
HB17 Auxiliary nurse (m/f)
HB03 Physical therapist / physiotherapist (m/f) in Kooperation Praxiseinsätze im Krankenhaus
HB18 Emergency paramedics (m/f) (training period 3 years) In Kooperation/Praxiseinsätze im Krankenhaus

Monika Döbl

Qualitätsmanagement

Phone: 04531 -68-2443
Mail: moc.soipelksa@lbeod.m

Monika Döbl

Assistenz der GF, QM & Marketing,

Phone: 04531 -68-2443
Mail: moc.soipelksa@lbeod.m

Dr. Ralph Tölg

Ärztlicher Direktor, Chefarzt Innere Medizin / Kardiologie

Phone: --
Mail: moc.soipelksa@gleot.r

PD Dr. Ralph Tölg

Ärztlicher Direktor

Phone: 04531 -68-0
Mail: moc.soipelksa@gleot.r